Şirket borçlanma araçları
Aşağıda, vadeye kalan getiriye göre sıralanmış AbbVie, Inc. tahvillerinin listesi bulunmaktadır. Yatırımcılar, piyasa oynaklığı zamanlarında artan istikrarları nedeniyle genellikle bir şirketin tahvillerini tercih ederler. Fiyatları, getirileri ve diğer istatistikleri inceleyin ve güvenilir bir yatırım bulun.
Sembol | YTM % | Hacim | Fiyat % | Kupon % | Vade Tarihi | Ödenmemiş tutar | Nominal değer | Asgari brm tutarı | İhraççı |
|---|---|---|---|---|---|---|---|---|---|
| AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045 | 7,00% | 26 K | 76,04% | 4,750% | 2045-03-15 | 53,51 M USD | 1.000,00 USD | 2.000,00 USD | Allergan Funding SCS |
| AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 6,40% | 12 K | 83,25% | 4,850% | 2044-06-15 | 65,23 M USD | 1.000,00 USD | 2.000,00 USD | Allergan Funding SCS |
| AACT3910526Actavis, Inc. 4.625% 01-OCT-2042 | 6,38% | 124 K | 81,98% | 4,625% | 2042-10-01 | 67,49 M USD | 1.000,00 USD | 2.000,00 USD | Actavis, Inc. |
| AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 5,79% | 250 K | 91,22% | 4,550% | 2035-03-15 | 107,65 M USD | 1.000,00 USD | 2.000,00 USD | Allergan Funding SCS |
| 5,69% | 1,16 M | 96,91% | 5,500% | 2064-03-15 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,61% | 768 K | 96,49% | 5,400% | 2054-03-15 | 3 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,61% | 127 K | 100,12% | 5,600% | 2055-03-15 | 750 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,59% | 0 | 86,23% | 4,450% | 2046-05-14 | 2 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,58% | 316 K | 90,95% | 4,875% | 2048-11-14 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,57% | 7,13 M | 82,31% | 4,250% | 2049-11-21 | 5,75 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,55% | 0 | 89,95% | 4,700% | 2045-05-14 | 2,7 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,51% | 120 K | 92,64% | 4,850% | 2044-06-15 | 1,01 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,50% | 191 K | 91,05% | 4,750% | 2045-03-15 | 827,09 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,49% | 26 K | 90,47% | 3,200% | 2029-11-21 | 62,52 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,45% | 1,74 M | 98,83% | 5,350% | 2044-03-15 | 750 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,43% | 0 | 88,69% | 4,400% | 2042-11-06 | 2,6 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,36% | 765 K | 91,34% | 4,625% | 2042-10-01 | 389,22 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,18% | 6,54 M | 88,96% | 4,050% | 2039-11-21 | 4 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,89% | 0 | 95,24% | 4,300% | 2036-05-14 | 1 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,82% | 0 | 97,63% | 4,500% | 2035-05-14 | 2,5 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,78% | 1,77 M | 103,06% | 5,200% | 2035-03-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,76% | 15,51 M | 98,48% | 4,550% | 2035-03-15 | 1,68 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,66% | 4,23 M | 102,54% | 5,050% | 2034-03-15 | 3 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,24% | 2,1 M | 103,21% | 4,950% | 2031-03-15 | 2 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,09% | 1,93 M | 102,88% | 4,875% | 2030-03-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,06% | 18,21 M | 96,99% | 3,200% | 2029-11-21 | 5,44 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,98% | 2,19 M | 102,37% | 4,800% | 2029-03-15 | 2,5 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,92% | 0 | 99,81% | 3,200% | 2026-05-14 | 2 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,85% | 2,21 M | 101,01% | 4,250% | 2028-11-14 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,84% | 1,25 M | 101,62% | 4,650% | 2028-03-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,81% | 18,64 M | 101,07% | 4,800% | 2027-03-15 | 2,25 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,81% | 4,66 M | 99,33% | 2,950% | 2026-11-21 | 3,99 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| XXS162262122Allergan Funding SCS 2.125% 01-JUN-2029 | 3,70% | 0 | 95,14% | 2,125% | 2029-06-01 | 36,46 M EUR | 1.000,00 EUR | 100.000,00 EUR | Allergan Funding SCS |
| 3,54% | 0 | 97,61% | 2,625% | 2028-11-15 | 72,11 M EUR | 1.000,00 EUR | 100.000,00 EUR | Allergan Funding SCS | |
| 3,16% | 0 | 126,76% | 4,750% | 2045-03-15 | 5 K USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,13% | 0 | 128,71% | 4,850% | 2044-06-15 | 100 K USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,13% | 0 | 121,31% | 4,250% | 2049-11-21 | 4,95 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,01% | 0 | 90,78% | 1,250% | 2031-11-18 | 650 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
| 2,60% | 0 | 98,49% | 2,125% | 2029-06-01 | 506,09 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
| 2,57% | 0 | 123,74% | 4,550% | 2035-03-15 | 1 K USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 2,56% | 0 | 98,84% | 2,125% | 2028-11-17 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
| 2,50% | 0 | 100,32% | 2,625% | 2028-11-15 | 427,79 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
| 2,40% | 0 | 97,15% | 0,750% | 2027-11-18 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
| −5,92% | 0 | 98,80% | 2,950% | 2026-11-21 | 9,24 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| — | — | — | 4,400% | 2042-11-06 | 1,1 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |